Position in PCRX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$53,359,323
+$6,789,833 QoQ
Shares Held
2,103,245
+2.1% QoQ
Ownership
5.28%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#4
of 254 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 94%
Shared 4%
None 2%
Common Shares in PCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $3,170,376,127 across 48 Drug Manufacturers - Specialty & Generic names. PCRX ranks #16 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
25,417,271 | $625,519,037 | |
| 2 | VTRS |
Viatris Inc
|
29,970,094 | $475,925,092 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
527,904 | $286,034,221 | |
| 4 | ALKS |
Alkermes plc.
|
4,194,873 | $219,811,343 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
1,466,260 | $162,666,882 | |
| 6 | ZTS |
Zoetis Inc.
|
2,173,278 | $156,171,754 | |
| 7 | PBH |
Prestige Consumer Healthcare Inc.
|
2,661,291 | $125,799,224 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
732,877 | $123,519,088 |
All Filings in PCRX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $53,359,323 | 2,103,245 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $46,569,490 | 2,060,597 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $50,466,334 | 1,950,013 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $55,752,698 | 2,163,473 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $51,424,243 | 2,151,642 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $50,928,358 | 2,049,431 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $34,518,947 | 1,832,216 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $28,179,166 | 1,872,370 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $52,300,938 | 1,828,065 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $47,603,148 | 1,629,129 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $47,633,016 | 1,411,767 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $42,762,334 | 1,393,818 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $44,969,517 | 1,122,274 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $40,368,310 | 989,177 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $36,577,914 | 947,369 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $46,659,754 | 877,228 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $47,184,286 | 809,336 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $57,880,706 | 758,395 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $45,415,894 | 754,793 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $40,017,712 | 714,602 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $47,505,886 | 782,892 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $43,004,981 | 613,568 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $34,450,905 | 575,717 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $33,496,699 | 557,164 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $28,559,788 | 544,307 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $17,715,072 | 528,335 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||